Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Annexin A1 peptide and endothelial cell-conditioned medium modulate cervical tumorigenesis.

Cardin LT, Prates J, da Cunha BR, Tajara EH, Oliani SM, Rodrigues-Lisoni FC.

FEBS Open Bio. 2019 Mar 5;9(4):668-681. doi: 10.1002/2211-5463.12603. eCollection 2019 Apr.

2.

Shared heritability and functional enrichment across six solid cancers.

Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, Aldrich MC, Andrew AS, Andrulis IL, Anton-Culver H, Antoniou AC, Antonenkova NN, Arnold SM, Aronson KJ, Arun BK, Bandera EV, Barkardottir RB, Barnes DR, Batra J, Beckmann MW, Benitez J, Benlloch S, Berchuck A, Berndt SI, Bickeböller H, Bien SA, Blomqvist C, Boccia S, Bogdanova NV, Bojesen SE, Bolla MK, Brauch H, Brenner H, Brenton JD, Brook MN, Brunet J, Brunnström H, Buchanan DD, Burwinkel B, Butzow R, Cadoni G, Caldés T, Caligo MA, Campbell I, Campbell PT, Cancel-Tassin G, Cannon-Albright L, Campa D, Caporaso N, Carvalho AL, Chan AT, Chang-Claude J, Chanock SJ, Chen C, Christiani DC, Claes KBM, Claessens F, Clements J, Collée JM, Correa MC, Couch FJ, Cox A, Cunningham JM, Cybulski C, Czene K, Daly MB, deFazio A, Devilee P, Diez O, Gago-Dominguez M, Donovan JL, Dörk T, Duell EJ, Dunning AM, Dwek M, Eccles DM, Edlund CK, Edwards DRV, Ellberg C, Evans DG, Fasching PA, Ferris RL, Liloglou T, Figueiredo JC, Fletcher O, Fortner RT, Fostira F, Franceschi S, Friedman E, Gallinger SJ, Ganz PA, Garber J, García-Sáenz JA, Gayther SA, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, Goode EL, Goodman MT, Goodman G, Grankvist K, Greene MH, Gronberg H, Gronwald J, Guénel P, Håkansson N, Hall P, Hamann U, Hamdy FC, Hamilton RJ, Hampe J, Haugen A, Heitz F, Herrero R, Hillemanns P, Hoffmeister M, Høgdall E, Hong YC, Hopper JL, Houlston R, Hulick PJ, Hunter DJ, Huntsman DG, Idos G, Imyanitov EN, Ingles SA, Isaacs C, Jakubowska A, James P, Jenkins MA, Johansson M, Johansson M, John EM, Joshi AD, Kaneva R, Karlan BY, Kelemen LE, Kühl T, Khaw KT, Khusnutdinova E, Kibel AS, Kiemeney LA, Kim J, Kjaer SK, Knight JA, Kogevinas M, Kote-Jarai Z, Koutros S, Kristensen VN, Kupryjanczyk J, Lacko M, Lam S, Lambrechts D, Landi MT, Lazarus P, Le ND, Lee E, Lejbkowicz F, Lenz HJ, Leslie G, Lessel D, Lester J, Levine DA, Li L, Li CI, Lindblom A, Lindor NM, Liu G, Loupakis F, Lubiński J, Maehle L, Maier C, Mannermaa A, Marchand LL, Margolin S, May T, McGuffog L, Meindl A, Middha P, Miller A, Milne RL, MacInnis RJ, Modugno F, Montagna M, Moreno V, Moysich KB, Mucci L, Muir K, Mulligan AM, Nathanson KL, Neal DE, Ness AR, Neuhausen SL, Nevanlinna H, Newcomb PA, Newcomb LF, Nielsen FC, Nikitina-Zake L, Nordestgaard BG, Nussbaum RL, Offit K, Olah E, Olama AAA, Olopade OI, Olshan AF, Olsson H, Osorio A, Pandha H, Park JY, Pashayan N, Parsons MT, Pejovic T, Penney KL, Peters WHM, Phelan CM, Phipps AI, Plaseska-Karanfilska D, Pring M, Prokofyeva D, Radice P, Stefansson K, Ramus SJ, Raskin L, Rennert G, Rennert HS, van Rensburg EJ, Riggan MJ, Risch HA, Risch A, Roobol MJ, Rosenstein BS, Rossing MA, De Ruyck K, Saloustros E, Sandler DP, Sawyer EJ, Schabath MB, Schleutker J, Schmidt MK, Setiawan VW, Shen H, Siegel EM, Sieh W, Singer CF, Slattery ML, Sorensen KD, Southey MC, Spurdle AB, Stanford JL, Stevens VL, Stintzing S, Stone J, Sundfeldt K, Sutphen R, Swerdlow AJ, Tajara EH, Tangen CM, Tardon A, Taylor JA, Teare MD, Teixeira MR, Terry MB, Terry KL, Thibodeau SN, Thomassen M, Bjørge L, Tischkowitz M, Toland AE, Torres D, Townsend PA, Travis RC, Tung N, Tworoger SS, Ulrich CM, Usmani N, Vachon CM, Van Nieuwenhuysen E, Vega A, Aguado-Barrera ME, Wang Q, Webb PM, Weinberg CR, Weinstein S, Weissler MC, Weitzel JN, West CML, White E, Whittemore AS, Wichmann HE, Wiklund F, Winqvist R, Wolk A, Woll P, Woods M, Wu AH, Wu X, Yannoukakos D, Zheng W, Zienolddiny S, Ziogas A, Zorn KK, Lane JM, Saxena R, Thomas D, Hung RJ, Diergaarde B, McKay J, Peters U, Hsu L, García-Closas M, Eeles RA, Chenevix-Trench G, Brennan PJ, Haiman CA, Simard J, Easton DF, Gruber SB, Pharoah PDP, Price AL, Pasaniuc B, Amos CI, Kraft P, Lindström S.

Nat Commun. 2019 Jan 25;10(1):431. doi: 10.1038/s41467-018-08054-4.

3.

Differentially expressed proteins in positive versus negative HNSCC lymph nodes.

Vidotto A, Polachini GM, de Paula-Silva M, Oliani SM, Henrique T, López RVM, Cury PM, Nunes FD, Góis-Filho JF, de Carvalho MB, Leopoldino AM, Tajara EH.

BMC Med Genomics. 2018 Aug 29;11(1):73. doi: 10.1186/s12920-018-0382-6.

4.

Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers.

Kachuri L, Saarela O, Bojesen SE, Davey Smith G, Liu G, Landi MT, Caporaso NE, Christiani DC, Johansson M, Panico S, Overvad K, Trichopoulou A, Vineis P, Scelo G, Zaridze D, Wu X, Albanes D, Diergaarde B, Lagiou P, Macfarlane GJ, Aldrich MC, Tardón A, Rennert G, Olshan AF, Weissler MC, Chen C, Goodman GE, Doherty JA, Ness AR, Bickeböller H, Wichmann HE, Risch A, Field JK, Teare MD, Kiemeney LA, van der Heijden EHFM, Carroll JC, Haugen A, Zienolddiny S, Skaug V, Wünsch-Filho V, Tajara EH, Ayoub Moysés R, Daumas Nunes F, Lam S, Eluf-Neto J, Lacko M, Peters WHM, Le Marchand L, Duell EJ, Andrew AS, Franceschi S, Schabath MB, Manjer J, Arnold S, Lazarus P, Mukeriya A, Swiatkowska B, Janout V, Holcatova I, Stojsic J, Mates D, Lissowska J, Boccia S, Lesseur C, Zong X, McKay JD, Brennan P, Amos CI, Hung RJ.

Int J Epidemiol. 2018 Jul 28. doi: 10.1093/ije/dyy140. [Epub ahead of print]

5.

JMJD1A, H3K9me1, H3K9me2 and ADM expression as prognostic markers in oral and oropharyngeal squamous cell carcinoma.

Maia LL, Peterle GT, Dos Santos M, Trivilin LO, Mendes SO, de Oliveira MM, Dos Santos JG, Stur E, Agostini LP, Couto CVMDS, Dalbó J, de Assis ALEM, Archanjo AB, Mercante AMDC, Lopez RVM, Nunes FD, de Carvalho MB, Tajara EH, Louro ID, Álvares-da-Silva AM.

PLoS One. 2018 Mar 28;13(3):e0194884. doi: 10.1371/journal.pone.0194884. eCollection 2018.

6.

Genomic analysis of head and neck cancer cases from two high incidence regions.

Perdomo S, Anantharaman D, Foll M, Abedi-Ardekani B, Durand G, Reis Rosa LA, Holmila R, Le Calvez-Kelm F, Tajara EH, Wünsch-Filho V, Levi JE, Vilensky M, Polesel J, Holcatova I, Simonato L, Canova C, Lagiou P, McKay JD, Brennan P.

PLoS One. 2018 Jan 29;13(1):e0191701. doi: 10.1371/journal.pone.0191701. eCollection 2018.

7.

ATM, BCL2, and TGFβ Gene Polymorphisms as Radiotherapy Outcome Biomarkers in Head and Neck Squamous Cell Carcinoma Patients.

Agostini LP, Stur E, Garcia FM, Ventorim DP, Dos Reis RS, Dettogni RS, Dos Santos EVW, Peterle GT, Maia LL, Mendes SO, de Carvalho MB, Tajara EH, de Paula F, Dos Santos M, da Silva AMA, Louro ID.

Genet Test Mol Biomarkers. 2017 Dec;21(12):727-735. doi: 10.1089/gtmb.2017.0180. Epub 2017 Nov 14.

PMID:
29135311
8.

Overexpression of Antiangiogenic Vascular Endothelial Growth Factor Isoform and Splicing Regulatory Factors in Oral, Laryngeal and Pharyngeal Squamous Cell Carcinomas

Biselli-Chicote PM, Biselli JM, Cunha BR, Castro R, Maniglia JV, Neto DS, Tajara EH, Góis Filho JF, Fukuyama EE, Pavarino ÉC, Goloni-Bertollo EM.

Asian Pac J Cancer Prev. 2017 Aug 27;18(8):2171-2177.

9.

ANXA1Ac2-26 peptide, a possible therapeutic approach in inflammatory ocular diseases.

Cardin LT, Sonehara NM, Mimura KK, Ramos Dinarte Dos Santos A, da Silva WA Junior, Sobral LM, Leopoldino AM, da Cunha BR, Tajara EH, Oliani SM, Rodrigues-Lisoni FC.

Gene. 2017 May 30;614:26-36. doi: 10.1016/j.gene.2017.02.032. Epub 2017 Feb 28.

10.

Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer.

Anantharaman D, Abedi-Ardekani B, Beachler DC, Gheit T, Olshan AF, Wisniewski K, Wunsch-Filho V, Toporcov TN, Tajara EH, Levi JE, Moyses RA, Boccia S, Cadoni G, Rindi G, Ahrens W, Merletti F, Conway DI, Wright S, Carreira C, Renard H, Chopard P, McKay-Chopin S, Scelo G, Tommasino M, Brennan P, D'Souza G.

Int J Cancer. 2017 May 1;140(9):1968-1975. doi: 10.1002/ijc.30608. Epub 2017 Feb 14.

11.

Corrigendum to 'Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents' [Oral Oncol. 62 (2016) 20-27].

D'Souza G, Anantharaman D, Gheit T, Abedi-Ardekani B, Beachler DC, Conway DI, Olshan AF, Wunsch-Filho V, Toporcov TN, Ahrens W, Wisniewski K, Merletti F, Boccia S, Tajara EH, Zevallos JP, Levi JE, Weissler MC, Wright S, Scelo G, Mazul AL, Tommasino M, Cadoni G, Brennan P.

Oral Oncol. 2017 Feb;65:e1. doi: 10.1016/j.oraloncology.2016.12.023. Epub 2016 Dec 30. No abstract available.

12.

Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents.

D'Souza G, Anantharaman D, Gheit T, Abedi-Ardekani B, Beachler DC, Conway DI, Olshan AF, Wunsch-Filho V, Toporcov TN, Ahrens W, Wisniewski K, Merletti F, Boccia S, Tajara EH, Zevallos JP, Levi JE, Weissler MC, Wright S, Scelo G, Mazul AL, Tommasino M, Cadoni G, Brennan P.

Oral Oncol. 2016 Nov;62:20-27. doi: 10.1016/j.oraloncology.2016.09.005. Epub 2016 Sep 26. Erratum in: Oral Oncol. 2017 Feb;65:e1.

13.

Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.

Lesseur C, Diergaarde B, Olshan AF, Wünsch-Filho V, Ness AR, Liu G, Lacko M, Eluf-Neto J, Franceschi S, Lagiou P, Macfarlane GJ, Richiardi L, Boccia S, Polesel J, Kjaerheim K, Zaridze D, Johansson M, Menezes AM, Curado MP, Robinson M, Ahrens W, Canova C, Znaor A, Castellsagué X, Conway DI, Holcátová I, Mates D, Vilensky M, Healy CM, Szeszenia-Dąbrowska N, Fabiánová E, Lissowska J, Grandis JR, Weissler MC, Tajara EH, Nunes FD, de Carvalho MB, Thomas S, Hung RJ, Peters WH, Herrero R, Cadoni G, Bueno-de-Mesquita HB, Steffen A, Agudo A, Shangina O, Xiao X, Gaborieau V, Chabrier A, Anantharaman D, Boffetta P, Amos CI, McKay JD, Brennan P.

Nat Genet. 2016 Dec;48(12):1544-1550. doi: 10.1038/ng.3685. Epub 2016 Oct 17.

14.

Diabetes mellitus, metformin and head and neck cancer.

Figueiredo RA, Weiderpass E, Tajara EH, Ström P, Carvalho AL, de Carvalho MB, Kanda JL, Moyses RA, Wünsch-Filho V.

Oral Oncol. 2016 Oct;61:47-54. doi: 10.1016/j.oraloncology.2016.08.006. Epub 2016 Aug 26.

PMID:
27688104
15.

Euphorbia tirucalli modulates gene expression in larynx squamous cell carcinoma.

Franco-Salla GB, Prates J, Cardin LT, Dos Santos AR, Silva WA Jr, da Cunha BR, Tajara EH, Oliani SM, Rodrigues-Lisoni FC.

BMC Complement Altern Med. 2016 May 21;16:136. doi: 10.1186/s12906-016-1115-z.

16.

HNdb: an integrated database of gene and protein information on head and neck squamous cell carcinoma.

Henrique T, José Freitas da Silveira N, Henrique Cunha Volpato A, Mioto MM, Carolina Buzzo Stefanini A, Bachir Fares A, Gustavo da Silva Castro Andrade J, Masson C, Verónica Mendoza López R, Daumas Nunes F, Paulo Kowalski L, Severino P, Tajara EH.

Database (Oxford). 2016 Mar 24;2016. pii: baw026. doi: 10.1093/database/baw026. Print 2016.

17.

Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes.

Stefanini AC, da Cunha BR, Henrique T, Tajara EH.

Dis Markers. 2015;2015:946572. doi: 10.1155/2015/946572. Epub 2015 Dec 9. Review.

18.

Keratins 17 and 19 expression as prognostic markers in oral squamous cell carcinoma.

Coelho BA, Peterle GT, Santos M, Agostini LP, Maia LL, Stur E, Silva CV, Mendes SO, Almança CC, Freitas FV, Borçoi AR, Archanjo AB, Mercante AM, Nunes FD, Carvalho MB, Tajara EH, Louro ID, Silva-Conforti AM.

Genet Mol Res. 2015 Nov 25;14(4):15123-32. doi: 10.4238/2015.November.24.21.

19.

Leptin receptor expression and Gln223Arg polymorphism as prognostic markers in oral and oropharyngeal cancer.

Rodrigues PR, Maia LL, Santos M, Peterle GT, Alves LU, Takamori JT, Souza RP, Barbosa WM, Mercante AM, Nunes FD, Carvalho MB, Tajara EH, Louro ID, Silva-Conforti AM.

Genet Mol Res. 2015 Nov 25;14(4):14979-88. doi: 10.4238/2015.November.24.5.

20.

MTHFR C677T and A1298C polymorphisms as predictors of radiotherapy response in head and neck squamous cell carcinoma.

Anders QS, Stur E, Agostini LP, Garcia FM, Reis RS, Santos JA, Mendes SO, Maia LL, Peterle GT, Stange V, Carvalho MB, Tajara EH, Santos M, Silva-Conforti AM, Louro ID.

Genet Mol Res. 2015 Oct 27;14(4):13105-9. doi: 10.4238/2015.October.26.6.

21.

Prognostic significance of head and neck squamous cell carcinoma repair gene polymorphism.

Stur E, Agostini LP, Garcia FM, Peterle GT, Maia LL, Mendes SO, Anders QS, Reis RS, Santos JA, Ventorim DP, Carvalho MB, Tajara EH, Santos M, Paula F, Silva-Conforti AM, Louro ID.

Genet Mol Res. 2015 Oct 16;14(4):12446-54. doi: 10.4238/2015.October.16.11.

22.

FAS ligand expression in inflammatory infiltrate lymphoid cells as a prognostic marker in oral squamous cell carcinoma.

Peterle GT, Santos M, Mendes SO, Carvalho-Neto PB, Maia LL, Stur E, Agostini LP, Silva CV, Trivilin LO, Nunes FD, Carvalho MB, Tajara EH, Louro ID, Silva-Conforti AM.

Genet Mol Res. 2015 Sep 22;14(3):11145-53. doi: 10.4238/2015.September.22.8.

23.

DAP1 high expression increases risk of lymph node metastases in squamous cell carcinoma of the oral cavity.

Santos M, Maia LL, Silva CV, Peterle GT, Mercante AM, Nunes FD, Carvalho MB, Tajara EH, Louro ID, Silva-Conforti AM.

Genet Mol Res. 2015 Sep 8;14(3):10515-23. doi: 10.4238/2015.September.8.13.

24.

ANXA1Ac₂₋₂₆ peptide reduces ID1 expression in cervical carcinoma cultures.

Prates J, Franco-Salla GB, Dinarte Dos Santos AR, da Silva WA Jr, da Cunha BR, Tajara EH, Oliani SM, Rodrigues-Lisoni FC.

Gene. 2015 Oct 10;570(2):248-54. doi: 10.1016/j.gene.2015.06.021. Epub 2015 Jun 10.

25.

Validation of methylation markers for diagnosis of oral cavity cancer.

Arantes LM, de Carvalho AC, Melendez ME, Centrone CC, Góis-Filho JF, Toporcov TN, Caly DN, Tajara EH, Goloni-Bertollo EM, Carvalho AL; GENCAPO.

Eur J Cancer. 2015 Mar;51(5):632-41. doi: 10.1016/j.ejca.2015.01.060. Epub 2015 Feb 13.

PMID:
25686481
26.

PROX1 gene is differentially expressed in oral cancer and reduces cellular proliferation.

Rodrigues MF, de Oliveira Rodini C, de Aquino Xavier FC, Paiva KB, Severino P, Moyses RA, López RM, DeCicco R, Rocha LA, Carvalho MB, Tajara EH, Nunes FD.

Medicine (Baltimore). 2014 Dec;93(28):e192. doi: 10.1097/MD.0000000000000192.

27.

Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.

Gastardelo TS, Cunha BR, Raposo LS, Maniglia JV, Cury PM, Lisoni FC, Tajara EH, Oliani SM.

PLoS One. 2014 Dec 9;9(12):e111317. doi: 10.1371/journal.pone.0111317. eCollection 2014.

28.

Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models.

Sobral LM, Sousa LO, Coletta RD, Cabral H, Greene LJ, Tajara EH, Gutkind JS, Curti C, Leopoldino AM.

Mol Cancer. 2014 Feb 20;13:32. doi: 10.1186/1476-4598-13-32.

29.

Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.

López RV, Levi JE, Eluf-Neto J, Koifman RJ, Koifman S, Curado MP, Michaluart-Junior P, Figueiredo DL, Saggioro FP, de Carvalho MB, Kowalski LP, Abrahão M, de Góis-Filho F, Tajara EH, Waterboer T, Boffetta P, Brennan P, Wünsch-Filho V.

Cancer Causes Control. 2014 Apr;25(4):461-71. doi: 10.1007/s10552-014-0348-8. Epub 2014 Jan 29.

PMID:
24474236
30.

HIF-1alpha expression profile in intratumoral and peritumoral inflammatory cells as a prognostic marker for squamous cell carcinoma of the oral cavity.

Mendes SO, dos Santos M, Peterle GT, Maia Lde L, Stur E, Agostini LP, de Carvalho MB, Tajara EH, Louro ID, Trivilin LO, da Silva-Conforti AM.

PLoS One. 2014 Jan 9;9(1):e84923. doi: 10.1371/journal.pone.0084923. eCollection 2014.

31.

MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.

Severino P, Brüggemann H, Andreghetto FM, Camps C, Klingbeil Mde F, de Pereira WO, Soares RM, Moyses R, Wünsch-Filho V, Mathor MB, Nunes FD, Ragoussis J, Tajara EH.

BMC Cancer. 2013 Nov 9;13:533. doi: 10.1186/1471-2407-13-533.

32.

Study of small proline-rich proteins (SPRRs) in health and disease: a review of the literature.

Carregaro F, Stefanini AC, Henrique T, Tajara EH.

Arch Dermatol Res. 2013 Dec;305(10):857-66. doi: 10.1007/s00403-013-1415-9. Epub 2013 Oct 2. Review.

PMID:
24085571
33.

Genetic variability of inflammatory genes in the Brazilian population.

dos Santos M, Stur E, Maia LL, Agostini LP, Peterle GT, Mendes SO, Tajara EH, de Carvalho MB, Louro ID, Silva-Conforti AM.

Genet Test Mol Biomarkers. 2013 Nov;17(11):844-8. doi: 10.1089/gtmb.2013.0264. Epub 2013 Aug 3.

34.

FAS/FASL expression profile as a prognostic marker in squamous cell carcinoma of the oral cavity.

de Carvalho-Neto PB, dos Santos M, de Carvalho MB, Mercante AM, dos Santos VP, Severino P, Tajara EH, Louro ID, da Silva-Conforti AM.

PLoS One. 2013 Jul 19;8(7):e69024. doi: 10.1371/journal.pone.0069024. Print 2013.

35.

Significant differences in demographic, clinical, and pathological features in relation to smoking and alcohol consumption among 1,633 head and neck cancer patients.

Moyses RA, López RV, Cury PM, Siqueira SA, Curioni OA, Gois Filho JF, Figueiredo DL; Head and Neck Genome Project GENCAPO, Tajara EH, Michaluart P Jr.

Clinics (Sao Paulo). 2013 Jun;68(6):738-44. doi: 10.6061/clinics/2013(06)03.

36.

Proteomic approaches identify members of cofilin pathway involved in oral tumorigenesis.

Polachini GM, Sobral LM, Mercante AM, Paes-Leme AF, Xavier FC, Henrique T, Guimarães DM, Vidotto A, Fukuyama EE, Góis-Filho JF, Cury PM, Curioni OA, Michaluart P Jr, Silva AM, Wünsch-Filho V, Nunes FD, Leopoldino AM, Tajara EH.

PLoS One. 2012;7(12):e50517. doi: 10.1371/journal.pone.0050517. Epub 2012 Dec 5.

37.

FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx.

Dutra RL, de Carvalho MB, Dos Santos M, Mercante AM, Gazito D, de Cicco R, Group G, Tajara EH, Louro ID, da Silva AM.

PLoS One. 2012;7(11):e50747. doi: 10.1371/journal.pone.0050747. Epub 2012 Nov 30.

38.

Prognostic significance of NDRG1 expression in oral and oropharyngeal squamous cell carcinoma.

Dos Santos M, da Cunha Mercante AM, Nunes FD, Leopoldino AM, de Carvalho MB, Gazito D, López RV, Chiappini PB, de Carvalho Neto PB, Fukuyama EE; Head Neck Genome Project/GENCAPO, Tajara EH, Louro ID, da Silva AM.

Mol Biol Rep. 2012 Dec;39(12):10157-65. doi: 10.1007/s11033-012-1889-0. Epub 2012 Sep 13.

PMID:
22972152
39.

SET protein accumulates in HNSCC and contributes to cell survival: antioxidant defense, Akt phosphorylation and AVOs acidification.

Leopoldino AM, Squarize CH, Garcia CB, Almeida LO, Pestana CR, Sobral LM, Uyemura SA, Tajara EH, Silvio Gutkind J, Curti C.

Oral Oncol. 2012 Nov;48(11):1106-13. doi: 10.1016/j.oraloncology.2012.05.014. Epub 2012 Jun 26.

40.

Proteomics: methodologies and applications to the study of human diseases.

Barbosa EB, Vidotto A, Polachini GM, Henrique T, Marqui AB, Tajara EH.

Rev Assoc Med Bras (1992). 2012 May-Jun;58(3):366-75. Review. English, Portuguese.

41.

Homeobox gene expression profile indicates HOXA5 as a candidate prognostic marker in oral squamous cell carcinoma.

Rodini CO, Xavier FC, Paiva KB, De Souza Setúbal Destro MF, Moyses RA, Michaluarte P, Carvalho MB, Fukuyama EE; Head And Neck Genome Project Gencapo, Tajara EH, Okamoto OK, Nunes FD.

Int J Oncol. 2012 Apr;40(4):1180-8. doi: 10.3892/ijo.2011.1321. Epub 2011 Dec 29.

42.

Accumulation of the SET protein in HEK293T cells and mild oxidative stress: cell survival or death signaling.

Leopoldino AM, Squarize CH, Garcia CB, Almeida LO, Pestana CR, Polizello AC, Uyemura SA, Tajara EH, Gutkind JS, Curti C.

Mol Cell Biochem. 2012 Apr;363(1-2):65-74. doi: 10.1007/s11010-011-1158-x. Epub 2011 Dec 6.

PMID:
22143534
43.

ORAOV1 is amplified in oral squamous cell carcinoma.

Xavier FC, Rodini CO, Paiva KB, Destro MF, Severino P, Moyses RA; Head and Neck Genome Project GENCAPO, Tajara EH, Nunes FD.

J Oral Pathol Med. 2012 Jan;41(1):54-60. doi: 10.1111/j.1600-0714.2011.01053.x. Epub 2011 May 28.

PMID:
21623924
44.

Genomics and proteomics approaches to the study of cancer-stroma interactions.

Rodrigues-Lisoni FC, Peitl P Jr, Vidotto A, Polachini GM, Maniglia JV, Carmona-Raphe J, Cunha BR, Henrique T, Souza CF, Teixeira RA, Fukuyama EE, Michaluart P Jr, de Carvalho MB, Oliani SM; Head and Neck Genome Project GENCAPO, Tajara EH, Cury PM, de Carvalho MB, Dias-Neto E, Figueiredo DL, Fukuyama EE, Góis-Filho JF, Leopoldino AM, Mamede RC, Michaluart-Junior P, Moyses RA, Nóbrega FG, Nóbrega MP, Nunes FD, Ojopi EF, Serafini LN, Severino P, Silva AM, Silva WA Jr, Silveira NJ, Souza SC, Tajara EH, Wünsch-Filho V, Amar A, Bandeira CM, Braconi MA, Brandão LG, Brandão RM, Canto AL, Cerione M, Cicco R, Chagas MJ, Chedid H, Costa A, Cunha BR, Curioni OA, Fortes CS, Franzi SA, Frizzera AP, Gazito D, Guimarães PE, Kaneto CM, López RV, Macarenco R, Magalhães MR, Meneses C, Mercante AM, Pinheiro DG, Polachini GM, Rapoport A, Rodini CO, Rodrigues-Lisoni FC, Rodrigues RV, Rossi L, Santos AR, Santos M, Settani F, Silva FA, Silva IT, Souza TB, Stabenow E, Takamori JT, Valentim PJ, Vidotto A, Xavier FC, Yamagushi F, Cominato ML, Correa PM, Mendes GS, Paiva R, Ramos O, Silva C, Silva MJ, Tarlá MV.

BMC Med Genomics. 2010 May 4;3:14. doi: 10.1186/1755-8794-3-14.

45.

Salivary and serum proteomics in head and neck carcinomas: before and after surgery and radiotherapy.

Vidotto A, Henrique T, Raposo LS, Maniglia JV, Tajara EH.

Cancer Biomark. 2010-2011;8(2):95-107. doi: 10.3233/CBM-2011-0205.

PMID:
21896997
46.

Epigenetic silencing of CRABP2 and MX1 in head and neck tumors.

Calmon MF, Rodrigues RV, Kaneto CM, Moura RP, Silva SD, Mota LD, Pinheiro DG, Torres C, de Carvalho AF, Cury PM, Nunes FD, Nishimoto IN, Soares FA, da Silva AM, Kowalski LP, Brentani H, Zanelli CF, Silva WA Jr, Rahal P, Tajara EH, Carraro DM, Camargo AA, Valentini SR.

Neoplasia. 2009 Dec;11(12):1329-39.

47.

Peripheral position of CCND1 and HER-2/neu oncogenes within chromosome territories in esophageal and gastric cancers non-related to amplification and overexpression.

Bizari L, Tajara EH, Silva AE.

Genet Mol Biol. 2009 Apr;32(2):242-50. doi: 10.1590/S1415-47572009005000034. Epub 2009 Jun 1.

48.

Gene expression profiling reveals molecular marker candidates of laryngeal squamous cell carcinoma.

Colombo J, Fachel AA, De Freitas Calmon M, Cury PM, Fukuyama EE, Tajara EH, Cordeiro JA, Verjovski-Almeida S, Reis EM, Rahal P.

Oncol Rep. 2009 Mar;21(3):649-63.

PMID:
19212623
49.

Annexin A1 subcellular expression in laryngeal squamous cell carcinoma.

Alves VA, Nonogaki S, Cury PM, Wünsch-Filho V, de Carvalho MB, Michaluart-Júnior P, Moyses RA, Curioni OA, Figueiredo DL, Scapulatempo-Neto C, Parra ER, Polachini GM, Silistino-Souza R, Oliani SM, Silva-Júnior WA, Nobrega FG; Head and Neck Genome Project/GENCAPO, Tajara EH, Zago MA.

Histopathology. 2008 Dec;53(6):715-27. doi: 10.1111/j.1365-2559.2008.03186.x.

PMID:
19076685
50.

Global gene expression profiling of oral cavity cancers suggests molecular heterogeneity within anatomic subsites.

Severino P, Alvares AM, Michaluart P Jr, Okamoto OK, Nunes FD, Moreira-Filho CA, Tajara EH; Head and Neck Genome Project GENCAPO.

BMC Res Notes. 2008 Nov 13;1:113. doi: 10.1186/1756-0500-1-113.

Supplemental Content

Loading ...
Support Center